N․, P. D., & V․, H. P. K. Low molecular weight chitosan (∼20 kDa) exhibits in vivo anti-hyperglycemic effects through AKT/PI3K/FOXO pathway. Elsevier.
Chicago Style (17th ed.) CitationN․, Priyanka D․, and Harish Prashanth K․ V․. Low Molecular Weight Chitosan (∼20 KDa) Exhibits in Vivo Anti-hyperglycemic Effects Through AKT/PI3K/FOXO Pathway. Elsevier.
MLA (9th ed.) CitationN․, Priyanka D․, and Harish Prashanth K․ V․. Low Molecular Weight Chitosan (∼20 KDa) Exhibits in Vivo Anti-hyperglycemic Effects Through AKT/PI3K/FOXO Pathway. Elsevier.
Warning: These citations may not always be 100% accurate.